OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The GSK3β/Mcl-1 axis is regulated by both FLT3-ITD and Axl and determines the apoptosis induction abilities of FLT3-ITD inhibitors
Yang Qiu, Ying Li, Meng Chai, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Yang Qiu, Ying Li, Meng Chai, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Showing 11 citing articles:
AXL signaling in cancer: from molecular insights to targeted therapies
Monika Yadav, Anuj K. Sharma, Ketki Patne, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Monika Yadav, Anuj K. Sharma, Ketki Patne, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 3
Understanding mechanisms of resistance to FLT3 inhibitors in adult FLT3-mutated acute myeloid leukemia to guide treatment strategy
Martina Ruglioni, Stefania Crucitta, Giovanna Irene Luculli, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 201, pp. 104424-104424
Open Access | Times Cited: 12
Martina Ruglioni, Stefania Crucitta, Giovanna Irene Luculli, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 201, pp. 104424-104424
Open Access | Times Cited: 12
Pim kinase inhibitors increase gilteritinib cytotoxicity in FLT3-ITD acute myeloid leukemia through GSK-3β activation and c-Myc and Mcl-1 proteasomal degradation
Jonelle K. Lee, Aditi Chatterjee, Mario Scarpa, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 2, pp. 431-445
Open Access | Times Cited: 4
Jonelle K. Lee, Aditi Chatterjee, Mario Scarpa, et al.
Cancer Research Communications (2024) Vol. 4, Iss. 2, pp. 431-445
Open Access | Times Cited: 4
Downregulation of DDIT4 levels with borneol attenuates hepatotoxicity induced by gilteritinib
Yiming Yin, Yashi Cao, Yourong Zhou, et al.
Biochemical Pharmacology (2025) Vol. 236, pp. 116869-116869
Closed Access
Yiming Yin, Yashi Cao, Yourong Zhou, et al.
Biochemical Pharmacology (2025) Vol. 236, pp. 116869-116869
Closed Access
Heme oxygenase 1 confers gilteritinib resistance in FLT3-ITD acute myeloid leukemia in a STAT6-dependent manner
Tianzhuo Zhang, Danna Wei, Yun Zhan, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Tianzhuo Zhang, Danna Wei, Yun Zhan, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
PLM-101 is a novel and potent FLT3/RET inhibitor with less adverse effects in the treatment of acute myeloid leukemia
Yong June Choi, Jaewoo Park, Hyoyi Choi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115066-115066
Open Access | Times Cited: 4
Yong June Choi, Jaewoo Park, Hyoyi Choi, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115066-115066
Open Access | Times Cited: 4
Homoharringtonine enhances cytarabine-induced apoptosis in acute myeloid leukaemia by regulating the p38 MAPK/H2AX/Mcl-1 axis
Yang Qiu, Lu Bai, Haosen Zhao, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Yang Qiu, Lu Bai, Haosen Zhao, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Preclinical development of tuspetinib for the treatment of acute myeloid leukemia
Himangshu Sonowal, William G. Rice, Rafael Bejar, et al.
Cancer Research Communications (2024) Vol. 5, Iss. 1, pp. 74-83
Open Access | Times Cited: 1
Himangshu Sonowal, William G. Rice, Rafael Bejar, et al.
Cancer Research Communications (2024) Vol. 5, Iss. 1, pp. 74-83
Open Access | Times Cited: 1
Data from Pim Kinase Inhibitors Increase Gilteritinib Cytotoxicity in FLT3-ITD Acute Myeloid Leukemia Through GSK-3β Activation and c-Myc and Mcl-1 Proteasomal Degradation
Jonelle K. Lee, Aditi Chatterjee, Mario Scarpa, et al.
(2024)
Open Access
Jonelle K. Lee, Aditi Chatterjee, Mario Scarpa, et al.
(2024)
Open Access
Venetoclax Overcomes Sorafenib Resistance in Acute Myeloid Leukemia by Targeting BCL2
Xi Xu, Weiwei Ma, Guo Qiu, et al.
Biology (2023) Vol. 12, Iss. 10, pp. 1337-1337
Open Access | Times Cited: 1
Xi Xu, Weiwei Ma, Guo Qiu, et al.
Biology (2023) Vol. 12, Iss. 10, pp. 1337-1337
Open Access | Times Cited: 1
Homoharringtonine enhances cytarabine induced apoptosis in acute myeloid leukemia by regulating p38 MAPK/H2AX/Mcl-1 axis
Yang Qiu, Lu Bai, Haosen Zhao, et al.
Research Square (Research Square) (2023)
Open Access
Yang Qiu, Lu Bai, Haosen Zhao, et al.
Research Square (Research Square) (2023)
Open Access
